Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases

Clin Genitourin Cancer. 2019 Jun;17(3):e612-e617. doi: 10.1016/j.clgc.2019.03.002. Epub 2019 Mar 13.
No abstract available

Keywords: Bisphosphonate therapy; Bone metastases; Castration-resistant prostate cancer; Jaw necrosis; Ra-223.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant / drug therapy
  • Radioisotopes / administration & dosage
  • Radioisotopes / therapeutic use
  • Radium / administration & dosage*
  • Radium / therapeutic use
  • Treatment Outcome
  • Zoledronic Acid / adverse effects

Substances

  • Radioisotopes
  • Zoledronic Acid
  • radium Ra 223 dichloride
  • Radium